Why the study?
While the role of Factor V Leiden and prothrombin G20210A in venous thromboembolism is well known, uncertainties remain regarding their relationship with arterial thrombotic events, particularly coronary events.
What is the role of Factor V Leiden and prothrombin G20210A in acute myocardial infarction, and how should affected patients be managed?
What is the role of Factor V Leiden and prothrombin G20210A in acute myocardial infarction, and how should affected patients be managed?
This review highlights the importance of targeted thrombophilia screening in atypical ACS presentations and suggests extended DAPT may be safe and beneficial in these patients.
No takes yet. Share an insight, caveat, or question.
Uncertainties remain for hereditary thrombophilias in AMI risk; leaves open need for prospective studies before any screening changes.
Bădescu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: